Drug Interactions between Rexulti and sars-cov-2 (covid-19) mrna (tozinameran 12y+) bivalent booster vaccine
This report displays the potential drug interactions for the following 2 drugs:
- Rexulti (brexpiprazole)
- sars-cov-2 (covid-19) mrna (tozinameran 12y+) bivalent booster vaccine
Interactions between your drugs
No interactions were found between Rexulti and sars-cov-2 (covid-19) mrna (tozinameran 12y+) bivalent booster vaccine. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Rexulti
A total of 580 drugs are known to interact with Rexulti.
- Rexulti is in the drug class atypical antipsychotics.
- Rexulti is used to treat the following conditions:
sars-cov-2 (covid-19) mrna (tozinameran 12y+) bivalent booster vaccine
A total of 321 drugs are known to interact with sars-cov-2 (covid-19) mrna (tozinameran 12y+) bivalent booster vaccine.
- Sars-cov-2 (covid-19) mrna (tozinameran 12y+) bivalent booster vaccine is in the drug class viral vaccines.
- Sars-cov-2 (covid-19) mrna (tozinameran 12y+) bivalent booster vaccine is used to treat COVID-19.
Drug and food interactions
brexpiprazole food
Applies to: Rexulti (brexpiprazole)
Alcohol can increase the nervous system side effects of brexpiprazole such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with brexpiprazole. Do not use more than the recommended dose of brexpiprazole, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. Talk to your doctor or pharmacist if you have any questions or concerns.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.